Jeil Pharm up 9.35% amid rising stem cell theme

On the 8th, the stem cell theme rose 3.08% compared to the previous day, showing strength, while Jeil Pharm, a related stock attracting attention, surged 9.35% compared to the previous day. Jeil Pharm is known as a company spun off from Jeil Pharma Holdings.

[Graph] Price changes of major stocks in the stem cell theme



According to the analysis by Thinkpool Robo Algorithm RASSI, Jeil Pharm’s quant financial score is 12.65 points, which is lower in stability, profitability, and growth compared to the average of other stem cell-related stocks. This can be interpreted as Jeil Pharm having relatively low investment attractiveness compared to other stocks from a financial perspective. On the other hand, Donggu Bio Pharm ranked first in quant financial ranking with higher growth, stability, and profitability scores compared to the average of other stocks.

[Table] Top stocks by financial score within the theme


※ The quant financial score is the result of the robo algorithm analyzing each company’s sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.

※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist Thinkpool.

This content was produced with the assistance of AI translation services.